Q4 2024 MariMed Inc Earnings Call Transcript
Key Points
- MariMed Inc (MRMD) reported a record revenue of $158 million for the year, with $39 million in revenue during Q4.
- The company's wholesale team delivered strong growth, with a 29% year-over-year increase, selling products into 80% of dispensaries across Massachusetts, Maryland, and Illinois.
- MariMed Inc (MRMD) has completed all 10 revenue-generating projects started a few years ago, including new facilities in Missouri and Illinois, which are expected to contribute to market share gains.
- The company has a strong brand portfolio, with Betty's Eddies being the number one edible brand in Massachusetts and Maryland, and plans to introduce new products in several categories.
- MariMed Inc (MRMD) maintains one of the strongest balance sheets in the cannabis industry, with no significant debt maturities in 2025, allowing for potential M&A activities to expand brand distribution.
- Retail revenue declined by 4% year-over-year, primarily due to pricing pressures and increased competition, particularly in Illinois.
- The company's gross margin decreased year-over-year from 45.6% to 43.3%, impacted by price compression and reliance on third-party flour.
- SG&A expenses increased to $56.4 million, or 35.7% of revenue, due to higher headcount and compensation costs.
- Adjusted EBITDA for the full year decreased by 20%, largely due to margin compression and increased operating expenses.
- MariMed Inc (MRMD) has decided to discontinue providing formal financial guidance due to regulatory shifts and market volatility, which may create uncertainty for investors.
Good morning. My name is Angeline, and I will be your conference operator today. At this time, I would like to welcome everyone to the MariMed Inc., fourth quarter 2024 financial results conference call.
(Operator Instructions)
Thank you. I will now turn the line over to Sara Rosenfield, Brand Director at MariMed, to begin the conference. Please go ahead.
Good morning, everyone. I'm Sara Rosenfield, the Brand Director for Betty's Eddies, which is now the number one edible brand in Massachusetts and Maryland. I joined MariMed in 2022 and I'm excited to kick off today's 2024, fourth quarter and year-end earnings call. Joining the call today are Jon Levine, our Chief Executive Officer; Mario Pinho, our Chief Financial Officer; and Ryan Crandall, our Chief Revenue Officer.
This call will be archived on our investor relations website and contains forward-looking statements. Actual events or results may differ materially from these forward-looking statements and are subject to various risks
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
